atenolol has been researched along with Heart Valve Diseases in 7 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk." | 9.11 | Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). ( Bella, JN; Boman, K; Dahlöf, B; Devereux, RB; Gerdts, E; Liu, JE; Nieminen, MS; Olsen, MH; Papademetriou, V; Rokkedal, J; Wachtell, K, 2004) |
| "Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk." | 5.11 | Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). ( Bella, JN; Boman, K; Dahlöf, B; Devereux, RB; Gerdts, E; Liu, JE; Nieminen, MS; Olsen, MH; Papademetriou, V; Rokkedal, J; Wachtell, K, 2004) |
| " We also now have another bradycardic agent, ivabradine, which may prove very useful in heart failure patients who cannot tolerate a betablocker." | 4.84 | [What are the alternatives to betablockers in 2009?]. ( van de Borne, P, 2008) |
| "In the case of HOCM, left ventricular hypertrophy is the primary process." | 1.37 | [Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction]. ( Kuijpers, NW; Szatmári, V, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van de Borne, P | 1 |
| Kuijpers, NW | 1 |
| Szatmári, V | 1 |
| Merritt, JC | 1 |
| Niebauer, M | 1 |
| Tarakji, K | 1 |
| Hammer, D | 1 |
| Mills, RM | 1 |
| Olsen, MH | 1 |
| Wachtell, K | 1 |
| Bella, JN | 1 |
| Liu, JE | 1 |
| Boman, K | 1 |
| Gerdts, E | 1 |
| Papademetriou, V | 1 |
| Nieminen, MS | 1 |
| Rokkedal, J | 1 |
| Dahlöf, B | 1 |
| Devereux, RB | 1 |
| Merrick, AF | 1 |
| Odom, NJ | 1 |
| Keenan, DJ | 1 |
| Grotte, GJ | 1 |
| Cacciapuoti, F | 1 |
| Perrone, N | 1 |
| Diaspro, R | 1 |
| Galzerano, D | 1 |
| Gentile, S | 1 |
| Lapiello, B | 1 |
| Strauer, BE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Triple-Blind, Parallel Study to Investigate the Effect of Losartan Versus Atenolol on the Reduction of Morbidity and Mortality in Hypertensive Patients With Left Ventricular Hypertrophy[NCT00338260] | Phase 3 | 496 participants (Actual) | Interventional | 1995-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for atenolol and Heart Valve Diseases
| Article | Year |
|---|---|
[What are the alternatives to betablockers in 2009?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiomyopathies; Heart Failur | 2008 |
[Cardiac function in hypertension].
Topics: Atenolol; Cardiomegaly; Coronary Disease; Digitalis Glycosides; Heart Function Tests; Heart Valve Di | 1978 |
3 trials available for atenolol and Heart Valve Diseases
| Article | Year |
|---|---|
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).
Topics: Aged; Aged, 80 and over; Aortic Valve; Atenolol; Female; Heart Valve Diseases; Humans; Losartan; Mal | 2004 |
Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial.
Topics: Adult; Aged; Atenolol; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; D | 1995 |
Slowing of mitral valve annular calcium in systemic hypertension by nifedipine and comparisons with enalapril and atenolol.
Topics: Adult; Atenolol; Calcinosis; Echocardiography, Doppler; Enalapril; Female; Heart Valve Diseases; Hum | 1993 |
2 other studies available for atenolol and Heart Valve Diseases
| Article | Year |
|---|---|
[Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction].
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Atenolol; Cat Diseases; Cats; Echocardiography; Hea | 2011 |
Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary | 2003 |